Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

There are some missing funding sources for this article. Please refer to the correct funding statement below:

The studies in this manuscript were funded by Exelixis Inc.; PO1 National Institutes of Health grant (PO1CA085859); Pacific Northwest Prostate Cancer SPORE grant (P50CA097186); Prostate Cancer Foundation; Richard M. Lucas Foundation; and University of Washington Bridge funding. Two of the co-authors (DTA and FS) are employees of Exelixis. They were involved in study design, data analyses, decision to publish and preparation of the manuscript.

Reference

  1. 1. Nguyen HM, Ruppender N, Zhang X, Brown LG, Gross TS, et al. (2013) Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling. PLoS ONE 8(10): e78881

Citation: The PLOS ONE Staff (2014) Correction: Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling. PLoS ONE 9(8): e106797. https://doi.org/10.1371/journal.pone.0106797

Published: August 21, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.